- Home
- IMAB vs UHT Comparison
IMAB vs UHT Comparison
Compare IMAB & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- UHT
- Stock Information
- Founded
- IMAB 2014
- UHT 1986
- Country
- IMAB United States
- UHT United States
- Employees
- IMAB N/A
- UHT N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- UHT Real Estate Investment Trusts
- Sector
- IMAB Health Care
- UHT Real Estate
- Exchange
- IMAB Nasdaq
- UHT Nasdaq
- Market Cap
- IMAB 486.4M
- UHT 515.7M
- IPO Year
- IMAB 2020
- UHT N/A
- Fundamental
- Price
- IMAB $4.70
- UHT $36.45
- Analyst Decision
- IMAB Strong Buy
- UHT
- Analyst Count
- IMAB 6
- UHT 0
- Target Price
- IMAB $7.50
- UHT N/A
- AVG Volume (30 Days)
- IMAB 2.2M
- UHT 75.1K
- Earning Date
- IMAB 11-14-2025
- UHT 10-27-2025
- Dividend Yield
- IMAB N/A
- UHT 8.12%
- EPS Growth
- IMAB N/A
- UHT N/A
- EPS
- IMAB N/A
- UHT 1.30
- Revenue
- IMAB N/A
- UHT $100,639,000.00
- Revenue This Year
- IMAB N/A
- UHT N/A
- Revenue Next Year
- IMAB N/A
- UHT $0.81
- P/E Ratio
- IMAB N/A
- UHT $28.06
- Revenue Growth
- IMAB N/A
- UHT 0.74
- 52 Week Low
- IMAB $0.60
- UHT $34.56
- 52 Week High
- IMAB $6.79
- UHT $43.38
- Technical
- Relative Strength Index (RSI)
- IMAB 49.60
- UHT 39.58
- Support Level
- IMAB $4.13
- UHT $36.04
- Resistance Level
- IMAB $6.79
- UHT $37.16
- Average True Range (ATR)
- IMAB 0.72
- UHT 0.75
- MACD
- IMAB -0.14
- UHT 0.10
- Stochastic Oscillator
- IMAB 21.43
- UHT 55.10
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.